Histamine and tryptase in nasal lavage fluid after allergen challenge: Effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine-Reference-Cited by-同舟云学术

Histamine and tryptase in nasal lavage fluid after allergen challenge: Effect of 1 week of pretreatment with intranasal azelastine or systemic cetirizine

Published:1999-05 Issue:5 Volume:103 Page:768-772
ISSN:0091-6749
Container-title:Journal of Allergy and Clinical Immunology
language:en
Short-container-title:Journal of Allergy and Clinical Immunology

Author:

Jacobi Henrik H.,Skov Per S.,Poulsen Lars K.,Malling Hans-Jørgen,Mygind Niels

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference28 articles.

1. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs;Church;Br J Pharmacol,1980

2. Azelastine inhibits stimulated histamine release from human lung tissue in vitro but does not alter cyclic nucleotide content;Little;Agents Actions,1989

3. In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin;Okayama;Allergy,1994

4. Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human FceRI+ cells;Genovese;Clin Exp Allergy,1997

5. Antiallergic activity of H1-receptor antagonists assessed by nasal challenge;Bousquet;J Allergy Clin Immunol,1988

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. KAAACI Allergic Rhinitis Guidelines: Part 1. Update in pharmacotherapy;Allergy, Asthma & Respiratory Disease;2023

2. KAAACI Allergic Rhinitis Guidelines: Part 1. Update in Pharmacotherapy;Allergy, Asthma & Immunology Research;2023

3. An ultrasensitive electrochemical detection of tryptase using 3D macroporous reduced graphene oxide nanocomposites by one-pot electrochemical synthesis;Analytica Chimica Acta;2019-09

4. Modulation of Allergic Inflammation in the Nasal Mucosa of Allergic Rhinitis Sufferers With Topical Pharmaceutical Agents;Frontiers in Pharmacology;2019-03-29

5. MP29-02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite-allergic rhinitis;Allergy;2018-01-17